Comparing Actemra vs Tyenne
| Actemra (tocilizumab) | Tyenne (tocilizumab) |
|
|---|
| Actemra (tocilizumab) | Tyenne (tocilizumab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Giant Cell Arteritis, COVID-19, Rheumatoid Arthritis, Cytokine Release Syndrome, Polyarticular Juvenile Idiopathic Arthritis, Juvenile Idiopathic Arthritis, Systemic... View more |
Prescription only
Prescribed for Giant Cell Arteritis, COVID-19, Rheumatoid Arthritis, Cytokine Release Syndrome, Polyarticular Juvenile Idiopathic Arthritis, Juvenile Idiopathic Arthritis. Tyenne may also be used for... View more |
Related suggestions Rheumatoid Arthritis
COVID-19
Juvenile Idiopathic Arthritis
Giant Cell Arteritis
Popular comparisons
|
|||||||||||||||
| More about Actemra (tocilizumab) | More about Tyenne (tocilizumab) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Actemra has an average rating of 6.7 out of 10 from a total of 49 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 24% reported a negative effect. |
Tyenne has an average rating of 9.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Actemra side effects |
View all Tyenne side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Actemra prices |
View all Tyenne prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other tocilizumab brands include: Avtozma, Tofidence, Tyenne | Other tocilizumab brands include: Actemra, Avtozma, Tofidence | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
210 hours |
210 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 436 drugs are known to interact with Actemra:
|
A total of 436 drugs are known to interact with Tyenne:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
January 08, 2010 |
March 05, 2024 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.